Key result
Among 99 children <1 year of age with sustained tachyarrhythmia, 91 had supraventricular tachycardia, mostly caused by accessory pathways requiring multidrug therapy or catheter ablation.
Population
99 patients <1 year of age with sustained tachyarrhythmia, median age 30 days, median weight 4.2 kg.
Design
Cohort
Authors
Loading...
Multidrug therapy or ablation often needed for infant SVT; extends descriptive data but leaves open comparative effectiveness.
Observational (n=99)
No
In infants under 1 year with sustained tachyarrhythmias, mostly driven by accessory pathways, multidrug therapy is often required, while catheter ablation serves as an effective alternative for refractory cases or those with LV dysfunction.
Şahin et al. (2017) conducted an observational in Sustained tachyarrhythmia (n=99). Medical and/or ablation therapy was evaluated. Among 99 children <1 year of age with sustained tachyarrhythmia, 91 had supraventricular tachycardia, mostly caused by accessory pathways requiring multidrug therapy or catheter ablation.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: